Clin2
NCT06763367Possibly a fitNot yet recruiting

Centella mask for rosacea, acne, and melasma

RosaceaAcneCentellaMelasma

Part of Skin clinical trials.

This study tests whether a face mask containing Centella asiatica (a plant extract) can improve symptoms of rosacea, acne, or melasma over 8 weeks. It may help reduce redness, breakouts, or dark patches.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
18 years to 60 years
Study type
Interventional

Who can take part

  • You are 18 or older.
  • You have mild to moderate rosacea, acne, or melasma.
  • You can follow the study plan and attend follow-ups for 8 weeks.
  • You haven't used any relevant medication or treatment for your skin condition in the past month.
  • You are not pregnant, planning pregnancy, or breastfeeding.
  • You have no major health problems (like heart, kidney, or mental health issues).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07540702Recruiting
Platelet-Rich Fibrin vs. Tranexamic Acid for Melasma

This trial tests two injectable treatments for melasma (dark patches on the face): platelet-rich fibrin, which uses your own blood cells to promote healing, and tranexamic acid, a medication that may reduce pigmentation. The study will compare which works better for women with mild to moderate melasma.

Cairo, Cairo Governorate
NCT07137130Not yet recruiting
Tranexamic acid study for women with melasma

This study tests whether a medicine called tranexamic acid, taken as a pill or used on the skin, can help fade melasma in women with darker skin types. It aims to find a safe way to improve skin color and is relevant to those looking for new melasma treatment options. The trial compares the treatment to another study treatment without medicine. Participation is open to women aged 30 to 60 with darker skin tones who are not pregnant and are not using certain other skin or hormone treatments.

Central Jakarta, D.k.i Jakarta
NCT06454747Recruiting· Phase 2
Testing a new gel for moderate to severe melasma

This study tests a new gel (SM-030) for adults with moderate to severe melasma. If you join, you would use the gel on your face for a few months and stop other skin-lightening products, while applying the provided sunscreen every day.

Santa Tecla, La Libertad Department
NCT07121439Not yet recruiting
Combination serum for dark spots after acne and melasma

This trial tests a serum with ingredients like niacinamide to improve dark spots from acne and melasma, used alongside a laser treatment. It aims to see if the serum makes the laser more effective at lightening skin patches.

Jakarta Pusat, Jakarta Special Capital Region
NCT07749469Recruiting
Soothing skincare for mild to moderate acne in sensitive skin

This trial tests skincare products designed for people with sensitive skin who have mild to moderate acne. The goal is to see if they safely and effectively reduce acne without irritating sensitive skin.

Petaling Jaya, Selangor
NCT07448415Not yet recruiting· Phase 2/Phase 3
A skin treatment for facial melasma in women

This trial tests whether taking tranexamic acid (a medicine that helps reduce pigmentation) along with a skin treatment called microneedling is more effective for treating melasma than microneedling alone. It aims to help women with facial melasma achieve clearer, more even skin tone.

Hear when a new Rosacea trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.